A repeated-measures study was set up to evaluate intra- and inter-rater reliability of the SHAP-C.
Outcome measures: Studies were synthesised in narrative format and thematic analysis was used to provide a collective insight into the physiotherapists' perceptions.
The pregnancy outcome measures studied were gestational age, birth weight, miscarriage and hypertensive disorders.
With regard to high-risk level measures, studies are needed to investigate the implementation of recommended measures in CKD health practice.
As the measures studied are collected some time after birth, we do not know the true measures of the episiotomy at birth.
All patients affected by any clinical form of IHD were included, understanding that the secondary prevention measures studied are indicated for all IHD presentations.
Data of patients receiving tocilizumab or placebo in the MEASURE study were analysed.
The outcome measure studied was the number of eyes with attached retina following silicone oil removal at the last follow-up.
